Clinical Laserthermia Systems AB (publ)

OM:CLS B Stock Report

Market Cap: SEK 71.0m

Clinical Laserthermia Systems Balance Sheet Health

Financial Health criteria checks 6/6

Clinical Laserthermia Systems has a total shareholder equity of SEK58.2M and total debt of SEK1.2M, which brings its debt-to-equity ratio to 2%. Its total assets and total liabilities are SEK68.5M and SEK10.3M respectively.

Key information

2.0%

Debt to equity ratio

SEK 1.19m

Debt

Interest coverage ration/a
CashSEK 15.58m
EquitySEK 58.20m
Total liabilitiesSEK 10.28m
Total assetsSEK 68.49m

Recent financial health updates

Recent updates

We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Jan 03
We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Aug 26
Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

Mar 01
Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

Financial Position Analysis

Short Term Liabilities: CLS B's short term assets (SEK31.3M) exceed its short term liabilities (SEK10.1M).

Long Term Liabilities: CLS B's short term assets (SEK31.3M) exceed its long term liabilities (SEK223.0K).


Debt to Equity History and Analysis

Debt Level: CLS B has more cash than its total debt.

Reducing Debt: CLS B's debt to equity ratio has reduced from 99.6% to 2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CLS B has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: CLS B is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 04:02
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clinical Laserthermia Systems AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hans MählerNordea Markets
Erik NordströmRedeye
Gustaf MeyerRedeye